{"cluster": 36, "subcluster": 4, "abstract_summ": " Type 1 interferons have a broad antiviral activity in vitro and are currently evaluated in a clinical trial to treat MERS-CoV . We suggest to pay more attention to the dysregulated IFN-I production in COVID-19 . Approved drugs like suramin and ALK inhibitors are worthy of clinical trials ."}